News
EW
90.59
+0.96%
0.87
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Edwards Lifesciences (EW), Encompass Health (EHC) and Moderna (MRNA)
TipRanks · 3h ago
Edwards Lifesciences (EW) Stock Weighs DCF Fair Value Against High P/E Multiple
Simply Wall St · 14h ago
Weekly Report: what happened at EW last week (0615-0619)?
Weekly Report · 4d ago
Notable healthcare headlines for the week: Merck, Moderna, and Biogen in focus
Seeking Alpha · 5d ago
Does Expanded CMS TAVR Coverage Alter the Bull Case for Edwards Lifesciences (EW)?
Simply Wall St · 06/17 23:26
BTIG Sticks to Their Buy Rating for Edwards Lifesciences (EW)
TipRanks · 06/17 12:30
Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device
Benzinga · 06/16 17:52
Edwards Lifesciences hits 52-week high after Medicare coverage proposal
Seeking Alpha · 06/16 17:16
Broader Market Weakens as Energy and Software Stocks Fall
NASDAQ · 06/16 17:11
Stocks Supported by Lower Crude Oil Prices and Bond Yields
NASDAQ · 06/16 15:52
Stocks Indexes Finish Mostly Lower as Chipmakers Retreat
Barchart · 06/16 15:33
Edwards Lifesciences Price Target Maintained With a $100.00/Share by RBC Capital
Dow Jones · 06/16 13:45
RBC Capital Reiterates Outperform on Edwards Lifesciences, Maintains $100 Price Target
Benzinga · 06/16 13:35
Edwards Lifesciences (EW) Stock Could Be 11% Undervalued on Its TAVR and EVOQUE Story
Simply Wall St · 06/16 13:25
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Spyre Therapeutics (SYRE)
TipRanks · 06/16 13:03
Leerink ‘incrementally positive’ on Edwards Lifesciences after TAVR NCD proposal
TipRanks · 06/16 12:59
Edwards jumps after CMS proposes to expand TAVR coverage
TipRanks · 06/16 12:53
TAVR NCD proposal ‘uber bullish’ for Edwards Lifesciences, says Evercore ISI
TipRanks · 06/16 12:49
Edwards best positioned to benefit from CMS proposal, says TD Cowen
TipRanks · 06/16 12:43
Edwards Lifesciences up 3% to $89 after CMS coverage proposal for TAVR
TipRanks · 06/16 12:42
More
Webull provides a variety of real-time EW stock news. You can receive the latest news about Edwards Lifesciences Corp through multiple platforms. This information may help you make smarter investment decisions.
About EW
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.